Detalhe da pesquisa
1.
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
Lancet
; 403(10435): 1460-1471, 2024 Apr 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38554725
2.
A Comprehensive Review on the Role of Lurbinectedin in Soft Tissue Sarcomas.
Curr Treat Options Oncol
; 25(2): 176-190, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38324075
3.
Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial.
Lancet Oncol
; 24(8): 892-902, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37429302
4.
Pain in desmoid-type fibromatosis: Prevalence, determinants and prognosis value.
Int J Cancer
; 153(2): 407-416, 2023 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36883417
5.
Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study.
Br J Cancer
; 129(12): 1940-1948, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37914801
6.
Initial Active Surveillance Strategy for Patients with Peripheral Sporadic Primary Desmoid-Type Fibromatosis: A Multicentric Phase II Observational Trial.
Ann Surg Oncol
; 30(13): 8653-8659, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37777684
7.
Prognostic factors of the synovial sarcoma of the extremities: imaging does matter.
Eur Radiol
; 33(2): 1162-1173, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-35980435
8.
Systemic Therapy in Advanced Pleomorphic Liposarcoma: a Comprehensive Review.
Curr Treat Options Oncol
; 24(11): 1598-1613, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37843627
9.
Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma Group.
Int J Cancer
; 150(4): 645-653, 2022 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34562271
10.
A review of the efficacy of trabectedin as second-line treatment of advanced soft tissue sarcoma.
Future Oncol
; 18(30s): 5-11, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-36200935
11.
Trabectedin as second-line treatment in advanced soft tissue sarcoma: quality of life and safety outcomes.
Future Oncol
; 18(30s): 13-22, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-36200954
12.
Experience with second-line trabectedin in daily clinical practice: case studies.
Future Oncol
; 18(30s): 23-32, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-36200932
13.
Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities.
Cancer
; 127(16): 2934-2942, 2021 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33910263
14.
Determinants of the access to remote specialised services provided by national sarcoma reference centres.
BMC Cancer
; 21(1): 631, 2021 May 29.
Artigo
Inglês
| MEDLINE | ID: mdl-34049529
15.
Surgical management of soft tissue tumors of the abdominal wall: A retrospective study in a high-volume sarcoma center.
J Surg Oncol
; 124(4): 679-686, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-34120344
16.
Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 21(3): 456-466, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32066540
17.
Results of API-AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome-09 study.
Int J Cancer
; 146(2): 413-423, 2020 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31246277
18.
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Cancer
; 126(11): 2637-2647, 2020 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32129883
19.
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network.
Cancer
; 126(1): 98-104, 2020 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31536651
20.
Imatinib in combination with phosphoinositol kinase inhibitor buparlisib in patients with gastrointestinal stromal tumour who failed prior therapy with imatinib and sunitinib: a Phase 1b, multicentre study.
Br J Cancer
; 122(8): 1158-1165, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32147671